ici 106270 has been researched along with beta-endorphin in 1 studies
| Studies (ici 106270) | Trials (ici 106270) | Recent Studies (post-2010) (ici 106270) | Studies (beta-endorphin) | Trials (beta-endorphin) | Recent Studies (post-2010) (beta-endorphin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 6,480 | 409 | 444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez-Roman, M; Fuentes, JA; Naranjo, JR; Urdin, MC | 1 |
1 other study(ies) available for ici 106270 and beta-endorphin
| Article | Year |
|---|---|
Beta-endorphin: a common factor in the antihypertensive action of clonidine-type imidazolines in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; beta-Endorphin; Blood Pressure; Brimonidine Tartrate; Clonidine; Dose-Response Relationship, Drug; Endorphins; Hypertension; Imidazoles; Injections, Intraventricular; Male; Quinoxalines; Rats | 1985 |